Cargando…
PB1890: TRIAL IN PROGRESS: A PHASE II STUDY OF MIDOSTAURIN COMBINED WITH INDUCTION/CONSOLIDATION CHEMOTHERAPY AND AS SINGLE-AGENT MAINTENANCE IN PEDIATRIC PATENTS WITH FLT3-MUTATED ACUTE MYELOID LEUKEMIA
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430045/ http://dx.doi.org/10.1097/01.HS9.0000974384.39613.77 |
| _version_ | 1785090859572658176 |
|---|---|
| author | Reinhardt, Dirk Zwaan, Michel Pathak, Dhrubajyoti Sawicki, Dawid Burgmeyer, Lisa Tateu, Muriel Orphee Yokam Locatelli, Franco |
| author_facet | Reinhardt, Dirk Zwaan, Michel Pathak, Dhrubajyoti Sawicki, Dawid Burgmeyer, Lisa Tateu, Muriel Orphee Yokam Locatelli, Franco |
| author_sort | Reinhardt, Dirk |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10430045 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104300452023-08-17 PB1890: TRIAL IN PROGRESS: A PHASE II STUDY OF MIDOSTAURIN COMBINED WITH INDUCTION/CONSOLIDATION CHEMOTHERAPY AND AS SINGLE-AGENT MAINTENANCE IN PEDIATRIC PATENTS WITH FLT3-MUTATED ACUTE MYELOID LEUKEMIA Reinhardt, Dirk Zwaan, Michel Pathak, Dhrubajyoti Sawicki, Dawid Burgmeyer, Lisa Tateu, Muriel Orphee Yokam Locatelli, Franco Hemasphere Publication Only Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10430045/ http://dx.doi.org/10.1097/01.HS9.0000974384.39613.77 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Publication Only Reinhardt, Dirk Zwaan, Michel Pathak, Dhrubajyoti Sawicki, Dawid Burgmeyer, Lisa Tateu, Muriel Orphee Yokam Locatelli, Franco PB1890: TRIAL IN PROGRESS: A PHASE II STUDY OF MIDOSTAURIN COMBINED WITH INDUCTION/CONSOLIDATION CHEMOTHERAPY AND AS SINGLE-AGENT MAINTENANCE IN PEDIATRIC PATENTS WITH FLT3-MUTATED ACUTE MYELOID LEUKEMIA |
| title | PB1890: TRIAL IN PROGRESS: A PHASE II STUDY OF MIDOSTAURIN COMBINED WITH INDUCTION/CONSOLIDATION CHEMOTHERAPY AND AS SINGLE-AGENT MAINTENANCE IN PEDIATRIC PATENTS WITH FLT3-MUTATED ACUTE MYELOID LEUKEMIA |
| title_full | PB1890: TRIAL IN PROGRESS: A PHASE II STUDY OF MIDOSTAURIN COMBINED WITH INDUCTION/CONSOLIDATION CHEMOTHERAPY AND AS SINGLE-AGENT MAINTENANCE IN PEDIATRIC PATENTS WITH FLT3-MUTATED ACUTE MYELOID LEUKEMIA |
| title_fullStr | PB1890: TRIAL IN PROGRESS: A PHASE II STUDY OF MIDOSTAURIN COMBINED WITH INDUCTION/CONSOLIDATION CHEMOTHERAPY AND AS SINGLE-AGENT MAINTENANCE IN PEDIATRIC PATENTS WITH FLT3-MUTATED ACUTE MYELOID LEUKEMIA |
| title_full_unstemmed | PB1890: TRIAL IN PROGRESS: A PHASE II STUDY OF MIDOSTAURIN COMBINED WITH INDUCTION/CONSOLIDATION CHEMOTHERAPY AND AS SINGLE-AGENT MAINTENANCE IN PEDIATRIC PATENTS WITH FLT3-MUTATED ACUTE MYELOID LEUKEMIA |
| title_short | PB1890: TRIAL IN PROGRESS: A PHASE II STUDY OF MIDOSTAURIN COMBINED WITH INDUCTION/CONSOLIDATION CHEMOTHERAPY AND AS SINGLE-AGENT MAINTENANCE IN PEDIATRIC PATENTS WITH FLT3-MUTATED ACUTE MYELOID LEUKEMIA |
| title_sort | pb1890: trial in progress: a phase ii study of midostaurin combined with induction/consolidation chemotherapy and as single-agent maintenance in pediatric patents with flt3-mutated acute myeloid leukemia |
| topic | Publication Only |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430045/ http://dx.doi.org/10.1097/01.HS9.0000974384.39613.77 |
| work_keys_str_mv | AT reinhardtdirk pb1890trialinprogressaphaseiistudyofmidostaurincombinedwithinductionconsolidationchemotherapyandassingleagentmaintenanceinpediatricpatentswithflt3mutatedacutemyeloidleukemia AT zwaanmichel pb1890trialinprogressaphaseiistudyofmidostaurincombinedwithinductionconsolidationchemotherapyandassingleagentmaintenanceinpediatricpatentswithflt3mutatedacutemyeloidleukemia AT pathakdhrubajyoti pb1890trialinprogressaphaseiistudyofmidostaurincombinedwithinductionconsolidationchemotherapyandassingleagentmaintenanceinpediatricpatentswithflt3mutatedacutemyeloidleukemia AT sawickidawid pb1890trialinprogressaphaseiistudyofmidostaurincombinedwithinductionconsolidationchemotherapyandassingleagentmaintenanceinpediatricpatentswithflt3mutatedacutemyeloidleukemia AT burgmeyerlisa pb1890trialinprogressaphaseiistudyofmidostaurincombinedwithinductionconsolidationchemotherapyandassingleagentmaintenanceinpediatricpatentswithflt3mutatedacutemyeloidleukemia AT tateumurielorpheeyokam pb1890trialinprogressaphaseiistudyofmidostaurincombinedwithinductionconsolidationchemotherapyandassingleagentmaintenanceinpediatricpatentswithflt3mutatedacutemyeloidleukemia AT locatellifranco pb1890trialinprogressaphaseiistudyofmidostaurincombinedwithinductionconsolidationchemotherapyandassingleagentmaintenanceinpediatricpatentswithflt3mutatedacutemyeloidleukemia |